Overcoming the problem of the lack of an immune response to cancer: A possible haptogenic approach to cancer immunotherapy

Short Communication | DOI: https://doi.org/10.31579/2640-1053/072

Overcoming the problem of the lack of an immune response to cancer: A possible haptogenic approach to cancer immunotherapy

  • Patrick A Riley 1

The Totteridge Institute for Advanced Studies, The Grange, Grange Avenue, London N20 8AB UK. 

*Corresponding Author: Patrick A Riley, The Totteridge Institute for Advanced Studies, The Grange, Grange Avenue, London N20 8AB UK.

Citation: Patrick A Riley. (2021) Overcoming the problem of the lack of an immune response to cancer: A possible haptogenic approach to cancer immunotherapy. Cancer Research and Cellular Therapeutics. 5(1); Doi: 10.31579/2640-1053/072

Copyright: © 2021 Patrick A Riley, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,provided the original author and source are credited.

Received: 25 January 2021 | Accepted: 25 February 2021 | Published: 01 March 2021

Keywords: epigenetics, malignancy, melanoma, haptogesis, immunology

Abstract

Cancer cells possess a number of unusual features, most of which are explicable in the light of the theory of epigenetic carcinogenesis. This includes the remarkable failure of malignant cells to evoke an immunological response from the host which is ascribed to their deviant behaviour resulting from anomalous expression of normal gene products. Given this background a possible approach to eliciting a specific anti-cancer immune response is proposed which involves selective haptenation of an identifiable target protein.

Introduction

The theory that the fundamental pathogenesis of cancer involves initiation by somatic    mutation of genes that are responsible for the copying of the epigenetic pattern of differentiated cells during mitosis [1-3] is consistent with the evidence of major epigenetic abnormalities associated with cancer [4-6] and is remarkably powerful in enabling several unique and puzzling features of malignancy to be explained.

Cancer incidence reflects size and proliferation rate of tissue stem cells

Because the proposed defect is envisaged as resulting in inaccurate copying of the epigenetic  pattern during mitosis the association with the proliferation rate of stem cells is explained. Malignancy is rare in slowly proliferating tissues but relatively common in rapidly renewing tissues such as epithelia and the cancer incidence in proliferating tissue is related to factors that control the rate of turnover, such as the effect of hormones on tissues like the breast [7].  Furthermore, there is evidence to show that the cancer incidence is a function of the turn over  and number of stem cells that comprise a tissue [8]. All these observations are consistent with  the existence of an abnormality of the type described by the theory of epigenetic carcinogenesis.

Initiation is consistent with the involvement of a limited number of somatic mutations

The epigenetic carcinogenesis mechanism is consistent with a limited number of initiating somatic mutations as embodied by the model of cancer incidence of Armitage and Doll [9]. It seems likely that the initiating defect arises in some essential epigenetic replication mechanism such as the copying of the DNA methylation pattern [10-13] and may possibly also  involve failure of some quality control process such as the p53 mechanism [14-17]. Thus, assuming homozygosity, as little as 4 mutations could suffice to generate an initiated cell as suggested by mathematical modelling [18, 19].

The progressive nature of the basic error permits the explanation of multiple anomalies

Epigenetic carcinogenesis explains the observation of the multitude of genes that have been shown to be expressed in cancer cells. Malignancy is associated with a remarkably wide range of alterations in genetic expression including over- and under-expression of products that are normally associated with the tissue of origin such as the many oncogenes and tumour- suppressor genes that have been observed in various cancers [20], but also the production of  proteins that are normally silenced. These observations are consistent with the proposed defective epigenetic control of gene activation, including the loss of the specific gene silencing  pattern found in differentiated cells.

Epigenetic carcinogenesis accounts for the genomic instability which is a fundamental feature of cancer cells

The cytological diagnosis of cancer rests on a number of unusual criteria. The features of malignancy include cellular enlargement, increased nuclear/cytoplasmic ratio, nuclear hyperchromasia, prominent and large nucleoli, abnormal distribution of nuclear chromatin, the presence of abnormal mitoses, as well as nuclear membrane abnormalities and cellular and nuclear pleomorphism. These criteria essentially reflect various aspects of chromosomal instability (CIN) which include chromosome doublings, chromosomal fragmentation and other abnormalities occurring during mitosis which result in large-scale chaotic changes to the genome of cancer cells [21]. All these characteristics derive from abnormalities in the structure of the chromatin. Chromatin is the ultimate carrier of heritable epigenetic information. The packaging of chromatin is dependent on the structure of nucleosomes mediated through modification of histones. This in turn is directed by the local pattern of DNA     methylation, which is thus the primary determinant of chromatin architecture [22, 23]. Therefore, the proposed defect in epigenetic copying postulated by the theory of epigenetic carcinogenesis provides a mechanism to account for this feature.

The theory explains the apparent hypermutability of malignant cells

Given that the primary defect envisaged is one that results in error-prone epigenetic copying  it would be anticipated that new faults can arise at each mitosis. Such a process inevitably generates an expanding spectrum of abnormalities as the affected clone proliferates and simulates the behaviour characterised as hypermutation [24,25] and suggests an evolutionary  progression in which the most successful variants, such as those cells with more rapid growth or exhibiting invasive and metastatic properties, are selected which is consistent with the observed pattern of malignancy.

The notable absence of an immunological response to cancer

As noted by Burnet [26], given the extensive range of abnormalities associated with cancer cells, it is remarkable that there seems to be no general immunological response by the host  to their presence and this is a matter that has provoked a great deal of comment. A great deal  has been written about the possibility that part of the malignant syndrome includes the ability  to interfere with the immune response and much effort has gone into investigating the various immune ‘checkpoints’ that enable malignant cells to escape detection by antibodies or cytotoxic T-cells [27]. But it follows logically from the epigenetic carcinogenesis theory which proposes that the emergence of abnormal properties is due to the anomalous pattern  of expression of normal genes, a phenomenon which would not be expected to elicit an immune response. Some success has been demonstrated by the action of synthetic antibodies against a mutant form of the Braf oncogene [28], but this does not address the fundamental problem.

From an immunological point of view, the difficulty posed by the notion that the abnormalities exhibited by cancer cells derive from the anomalous pattern of expression of genes and not due to the abnormality of the genes themselves, is that it lacks a process that renders the products of the abnormally expressed genes immunologically recognizable. To bring this about requires a means of generating neo-antigens that will render the malignant cells ‘visible’ to the immune system.

Selective Haptenation as a general approach to cancer immunotherapy

One possible solution to this quandary is to selectively haptenize one or more gene products  that are constitutively expressed in malignant cells. Targets could be products implicated in the faulty epigenetic processes involved in rendering the cells abnormal, or one of the re- expressed gene products that endow the cells with their malignant potential. At present these targets remain obscure but the possibility of engaging the attention of the immune system by selective haptenation has been demonstrated in melanocytes as detailed below.

The initial studies emerged from work in identifying the mode of action of externally applied  agents that resulted in skin depigmentation. It had been shown by Oliver et al. [29] that contact with the monobenzyl ether of hydroquinone resulted in marked local depigmentation. A subsequent series of studies demonstrated that a series of phenols  possessed a similar action, that the effect was dependent of their oxidation by the melanocytic enzyme tyrosinase, and that the depigmentation was the result of the elimination of melanocytes from the affected skin [30-35]. Initially it was considered that this  was due to a direct melanocytotoxic action of the quinone oxidation product of the active agents.

The tyrosinase-specificity suggested a possible therapeutic strategy for the treatment of melanoma and a preliminary clinical trial was instigated in which 4-hydroxyanisole (4HA) was  infused intra-arterially. Morgan et al. [36] reported a clinical pilot study in which 4HA was administered to a group of melanoma patients with widespread disease unresponsive to other therapies. Despite the high doses administered, the acute responses were disappointing, suggesting that there was negligible direct cytotoxic action [35]. However, longer term follow-up showed that 45% of cases showed some degree of regression of tumours in the infused zone. There was no evidence of a generalised tumour response or of any distant cutaneous or ocular depigmentation. In one case there was complete regression of secondary tumours in the infused limb. This patient, with multiple recurrences at the site of a skin graft on the left leg, received two courses of 4HA (100 and 84 G by intra-femoral infusion) with a 4-week interval and, when seen 4 weeks after the second infusion, was tumour-free [37]. This delayed reaction would be explained by the initiation of an immune response specific to tyrosinase-expressing cells exposed to 4HA.

It had been observed that the loss of epidermal melanocytes resulting from the local application of depigmenting phenols that the absence of melanocytes was associated with an  increase in epidermal Langerhans cells [38] and it was proposed that this indicated the involvement of an immune response. Further investigations led to the proposal of an immune mechanism to account for the loss of melanocytes based on the haptenation of melanogenic proteins.

Figure 1: Schematic outline of the six stages of the selective haptenation process.

In brief, the proposed mechanism involves the oxidation by tyrosinase of the depigmenting phenol forming the ortho-quinone derivative. These compounds are known to be highly reactive and undergo facile nucleophilic addition reactions [39] binding to adjacent proteins including the enzyme itself. It has been demonstrated, using tritiated 4HA, that the product is covalently bound to tyrosinase [40]. It is proposed that the haptenized proteins are  processed by the proteosomal degradation pathway and the neoantigenic products exposed  at the cell surface [41]. Here they are recognised by local antigen-presenting cells such as Langerhans cells and this initiates an immune response that includes cytotoxic T-cells which eliminate the melanocytes bearing the haptenic antigen. It has been argued that this is the pathological process underlying vitiligo [42] which is regarded as a manifestation of an autoimmune disease initiated by the haptenation of melanosomal proteins. Since the majority of melanomas express tyrosinase activity, such a targeted haptenation mechanism would account for the results obtained in the preliminary clinical trial of the anti-melanoma treatment and constitutes the mechanistic basis of the melanocyte-directed enzyme prodrug  therapy (MDEPT) [43, 44]. The general process is outlined in Figure 1.

Conclusion

This approach suggests that a similar haptenation process could be employed as a therapeutic  modality where a suitable expressed enzyme or specific protein target can be identified in the malignant cell population. Spontaneous regression of widespread malignancies, although a comparatively rare occurrence, might suggest that such specific haptenation does take place, since a generalised immune response cannot be explained by a mutation that would affect all the clonal variants present in metastatic cancer. Thus, it is suggested that targeted haptenation could furnish a general means of eliciting anti-cancer immunity and might prove  practical as a possible therapeutic strategy.

Acknowledgements

I am grateful to my colleagues in the Quintox Group and to John Vince, Roger Dean and Mark Burkitt for encouragement, help and advice. I thank Charles Harding for much useful discussion and helpful comments concerning the mathematical modelling. The Totteridge Institute for Advanced Studies is in receipt of a grant from the Melanoma Research Foundation.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad